Sign up for free insights newsletter
Pharmaron Beijing Co Ltd

Pharmaron Beijing Co Ltd

300759SHE

Need professional-grade analysis? Visit stockanalysis.com

CN¥30.47
-2.93%
End of day
Market Cap

$55.63B

P/E Ratio

32.21

Employees

25,088

Dividend Yield

0.64%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.9140.28-0.23-0.111.475.59
Calmar-26.77-0.31-0.101.26-1.68
Sharpe-2.8715.18-0.15-0.070.912.09
Omega0.093.051.001.021.191.28
Martin-53.34-0.69-0.202.85-3.23
Ulcer1.471.098.2812.9412.729.59

Pharmaron Beijing Co Ltd (300759) Price Performance

Pharmaron Beijing Co Ltd (300759) trades on SHE in CNY. The company is classified in the Healthcare sector under the Biotechnology industry. The stock currently trades at CNY30.47, down 2.93% from the previous close.

Over the past year, 300759 has traded between a low of CNY22.04 and a high of CNY35.90. The stock has gained 38.3% over this period. It is currently 15.1% below its 52-week high.

Pharmaron Beijing Co Ltd has a market capitalization of $55.63B, with a price-to-earnings ratio of 32.21 and a dividend yield of 0.64%.

About Pharmaron Beijing Co Ltd

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.

Compare Pharmaron Beijing Co Ltd

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
SHE
Currency
CNY
Country
China

Financial Metrics

Revenue (TTM)
$14.10B
EBITDA
$3.05B
Profit Margin
11.81%
EPS (TTM)
0.94
Book Value
8.51

Technical Indicators

52 Week High
CN¥37.63
52 Week Low
CN¥21.81
50 Day MA
CN¥28.86
200 Day MA
CN¥30.32
Beta
0.91

Valuation

Trailing P/E
32.21
Forward P/E
26.81
Price/Sales
3.95
Price/Book
3.83
Enterprise Value
$58.54B